CD55 and Ewing sarcoma: While previous reports showed DAF lacked the capacity to transform NIH3T3 cells [24], we tested the ability of DAF to transform EWS/FLI-depleted Ewing sarcoma cells as a more disease relevant model (Figure 2H).